Rapporto sulle dimensioni del mercato del sistema di gestione della sperimentazione clinica | 2023-2031

  • Report Code : TIPHC00002241
  • Category : Healthcare IT
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

[Rapporto di ricerca] Si prevede che le dimensioni del mercato del sistema di gestione degli studi clinici cresceranno da 1.410,98 milioni di dollari nel 2022 a 2.061,86 milioni di dollari entro il 2030; Si stima che il mercato registrerà un CAGR del 12,56% dal 2022 al 2030.

Punto di vista dell'analista

L'analisi di mercato del sistema di gestione della sperimentazione clinica comporta fattori trainanti del mercato, come il numero crescente di nuove malattie croniche e attività di sviluppo di farmaci, che hanno portato a un numero crescente di sperimentazioni cliniche. Il crescente numero di sperimentazioni cliniche, a sua volta, spinge la domanda di sistemi di gestione delle sperimentazioni cliniche. Tuttavia, si prevede che il vincolo di bilancio ostacolerà la crescita del mercato durante il periodo di previsione. In base alla tipologia, il mercato è segmentato in Enterprise e On-site; il segmento del software rappresentava la quota di mercato maggiore nel 2022. Inoltre, l'integrazione del CTMS con il software esistente sta creando opportunità nel mercato dei sistemi di gestione delle sperimentazioni cliniche nel periodo dal 2023 al 2030. In base alla tipologia, il mercato Sistema di gestione della sperimentazione clinica è segmentato in Enterprise e On-site. Il segmento Enterprise ha rappresentato la quota di mercato maggiore nel 2022 e si prevede che crescerà con il CAGR più elevato.

Le sperimentazioni cliniche sono esperimenti condotti per garantire la sicurezza e l'efficacia dei nuovi trattamenti. Le aziende farmaceutiche, biotecnologiche o di dispositivi medici sponsorizzano questi studi per ottenere l'approvazione della FDA o di un'autorità di regolamentazione internazionale per i loro farmaci o dispositivi. Il Clinical Trial Management System (CTMS) è progettato per tenere traccia delle informazioni strutturate in modo intuitivo e logico, consentendo ai team di scienze della vita di monitorare e riferire sui progressi delle sperimentazioni cliniche, prendere decisioni più informate e fornire dati della migliore qualità garantendo al contempo la sicurezza dei pazienti.

Approfondimenti basati sull'utente finale

In termini di utenti, il mercato dei sistemi di gestione delle sperimentazioni cliniche è classificato in aziende farmaceutiche e biotecnologiche, aziende di dispositivi medici, CRO e altri. Il segmento delle aziende farmaceutiche e biotecnologiche ha detenuto la quota maggiore del mercato nel 2022 e si prevede che il segmento delle CRO registrerà il CAGR più elevato nel periodo 2022-2030 a causa dello spostamento degli studi di sperimentazione clinica alle CRO poiché il settore delle scienze della vita è attivamente coinvolto nell’esternalizzare lo sviluppo dei farmaci e gli studi di sperimentazione clinica alle CRO. Le CRO assistono nell'implementazione di successo delle sperimentazioni cliniche attraverso i servizi offerti utilizzando strutture di alta qualità e una profonda competenza in materia. Le CRO hanno iniziato a fungere da spina dorsale del settore delle sperimentazioni cliniche attraverso le loro operazioni efficienti ed economicamente vantaggiose a vantaggio degli sponsor delle sperimentazioni. Secondo il blog pubblicato su Thermo Fisher Scientific, nel 2022, circa 3 studi clinici su 4 sono stati condotti da CRO per rassicurare i programmi clinici degli sviluppatori di farmaci, fornire una vasta gamma di competenze, favorire l'efficienza in termini di tempi e costi e fornire soluzioni personalizzate, dati di alta qualità. Pertanto, lo sviluppo di soluzioni economicamente vantaggiose e la riduzione degli errori nelle CRO durante il processo di sviluppo dei farmaci stanno guidando la crescita del mercato degli studi clinici.

Sistema di gestione degli studi clinici, di Digita – 2022 e 2030

Analisi regionale

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. Oracle
2. Medidata Solutions Inc.
3. PAREXEL International Corporation.
4. MedNet Solutions, Inc.
5. Bioclinica
6. BioOptronics, Inc.
7. DATATRAK Int.
8. ERT Clinical
9. FORTE
10. ICON plc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports